CUSIP: 45114M109
Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
31,555,847
-
Share change
-
+58,408
-
Total reported value
-
$222,156,523
-
Price per share
-
$7.04
-
Number of holders
-
61
-
Value change
-
-$28,395,568
-
Number of buys
-
42
-
Number of sells
-
16
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2022
-
Previous quarter:
Q4 2021
Recent filing periods for CUSIP 45114M109:
Institutional Holders of ICOSAVAX INC - COM (ICVX) as of Q1 2022
As of 31 Mar 2022,
ICOSAVAX INC - COM (ICVX) was held by
61 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,555,847 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., Qiming U.S. Ventures Management, LLC, ADAMS STREET PARTNERS LLC, NanoDimension, Inc., FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., CITADEL ADVISORS LLC, PLATINUM INVESTMENT MANAGEMENT LTD, and PERCEPTIVE ADVISORS LLC.
This page lists
61
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.